Enhancing Vaccine Confidence and Uptake: Focus on HPV and Pneumococcal Disease

Primary prevention by immunization is the most effective means of reducing the burden of disease caused by pathogens such as human papillomavirus (HPV) and Streptococcus pneumoniae. HPV is a common sexually transmitted infection that can cause genital warts and cancers of the cervix, oropharynx, anus, vagina, and vulva. Pneumococcal disease (PD) spreads via respiratory secretions and can lead to sinusitis, otitis media, pneumonia, meningitis, and bacteremia. PD poses a significant burden on vulnerable patient populations such as young children and older adults, those with chronic conditions, and those who are immunocompromised. Highly effective and safe vaccines are available to prevent HPV infection and its sequalae as well as pneumococcal disease. Despite the proven benefits of available vaccines, immunization rates remain suboptimal, and vaccine hesitancy has been on the rise. Patient counseling and education is key to identifying high-risk patients and providing them with reliable information on available vaccines as well as where and how to get them. In this CE activity, expert faculty investigate the prevalence and burden of HPV infection and PD; discuss the safety, efficacy, and Advisory Committee on Immunization Practices (ACIP) guidelines for available vaccines; and assess strategies and interprofessional approaches to increase vaccine confidence in patients eligible for these immunizations.

Credits: 0.75 contact hours; 0.25 are pharmacology


As a result of this activity, the learner will be able to:

  1.   Investigate the prevalence, burden, and risk factors for HPV infection and pneumococcal diseases
  2.   Discuss the safety and efficacy of vaccines for HPV and pneumococcal disease including the latest ACIP guideline recommendations regarding their use.
  3.  Apply various strategies and interprofessional approaches to increase vaccine confidence of caregivers/patients with HPV and pneumococcal disease and enhance vaccine uptake.

Charles P. Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine; Director, UC Irvine Program in Medical Education for the Latino Community; Assistant Dean for Culture and Community Education, UC Irvine School of Medicine, Irvine, CA

Dr. Chuck Vega grew up in Northern California and completed his undergraduate degree at Harvard University. He attended medical school at the University of Wisconsin – Madison and completed residency training in Family Medicine at UC Irvine. He stayed on as faculty in the Department of Family Medicine at UCI and now holds the title of Health Sciences Clinical Professor. He is the Executive Director of UCI’s Program in Medical Education for the Latino Community and won a Macy Faculty Scholarship to improve patient-centered health education at UCI. He currently serves as Assistant Dean for Culture and Community Education in the UC Irvine School of Medicine. Dr. Vega has seen patients and taught medical students and residents at UC Irvine’s Family Health Center – Santa Ana for the past 20 years. This clinic is a federally-qualified health center and the largest safety-net clinic for Orange County. Dr. Vega’s academic interests are focused on access to quality, compassionate medical care for underserved populations, and the development of training programs to promote this vision of healthcare.

Rachel N. Caskey, MD, MAPP, FACP, FAAP

Chief, Division of Academic Internal Medicine; Professor of Medicine and Pediatrics. University of Illinois at Chicago, Chicago, IL

Dr. Rachel Caskey is a department affiliate with the Maternal and Child Health Program in the Community Health Science division and a Professor of Pediatrics and Medicine. She is board certified in both pediatrics and internal medicine and is a primary care provider for all ages. Dr. Caskey is the Chief of the Division of Academic Internal Medicine at UIC and a health services researcher. Her research focuses on investigating novel mechanisms to positively impact health behaviors which result in improved health outcomes, streamlined healthcare systems and cost savings. Her recent projects include health and public health interventions to improve outcomes for postpartum people. She leads system-level interventions to improve access to health and mental care during the postpartum period.

Dr. Caskey has served on several Chicago Department of Public Health committees and task forces. She works with the Illinois Chapter of the American Academy of Pediatrics on vaccine promotion efforts. Dr. Caskey speaks nationally about adolescent health and vaccine promotion.


Obtain Your Credits

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 5 out of 7 of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a Contact Hour Certificate or AAPA Category 1 CME Certificate.

Accreditation Statement

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation:

Vindico Medical Education will provide 0.75 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until October 30, 2024. PAs should only claim credit commensurate with the extent of their participation. 

This activity is approved for 0.75 contact hour(s) of continuing education (which includes 0.25 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23106402. This activity was planned in accordance with AANP Accreditation Standards and Policies.

This enduring material is approved for 1 year from the date of original release, October 31, 2023, to October 30, 2024.



Contributing faculty, Rachel N. Caskey, MD, MAPP, FACP, FAAP has disclosed no relevant financial relationships. 

Contributing faculty, Charles P. Vega, MD, FAAFP has disclosed:

Consultant: GSK



Advisor: Pfizer 

Speaker Contracted by Ineligible Company: Pfizer, Sanofi

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

No relevant financial relationships to disclose 

Linda A. Giarraputo, BS, PA-C

No relevant financial relationships to disclose

Vindico Medical Education Staff:

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.

Disclosure of Unlabeled Use

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices. 

Commercial Support

This activity is supported by an educational grant from Merck & Co., Inc.

Copyright Statement:

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher.

The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


8 Questions
7 Questions  |  1 attempt  |  0/7 points to pass
7 Questions  |  1 attempt  |  0/7 points to pass This pre-test is a non-graded assessment tool we use to establish a baseline and determine a participant's pre-existing knowledge.
Open to view video.
Open to view video.
Course Evaluation
23 Questions
7 Questions  |  Unlimited attempts  |  5/7 points to pass
7 Questions  |  Unlimited attempts  |  5/7 points to pass A satisfactory score is defined as answering 5 out of 7 of the posttest questions correctly.
0.75 Contact Hours credits  |  Certificate available
0.75 Contact Hours credits  |  Certificate available